Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Apr 5;1(1):18-28.
doi: 10.1016/j.bioactmat.2016.03.002. eCollection 2016 Sep.

Biomaterial property-controlled stem cell fates for cardiac regeneration

Affiliations
Review

Biomaterial property-controlled stem cell fates for cardiac regeneration

Yanyi Xu et al. Bioact Mater. .

Abstract

Myocardial infarction (MI) affects more than 8 million people in the United States alone. Due to the insufficient regeneration capacity of the native myocardium, one widely studied approach is cardiac tissue engineering, in which cells are delivered with or without biomaterials and/or regulatory factors to fully regenerate the cardiac functions. Specifically, in vitro cardiac tissue engineering focuses on using biomaterials as a reservoir for cells to attach, as well as a carrier of various regulatory factors such as growth factors and peptides, providing high cell retention and a proper microenvironment for cells to migrate, grow and differentiate within the scaffolds before implantation. Many studies have shown that the full establishment of a functional cardiac tissue in vitro requires synergistic actions between the seeded cells, the tissue culture condition, and the biochemical and biophysical environment provided by the biomaterials-based scaffolds. Proper electrical stimulation and mechanical stretch during the in vitro culture can induce the ordered orientation and differentiation of the seeded cells. On the other hand, the various scaffolds biochemical and biophysical properties such as polymer composition, ligand concentration, biodegradability, scaffold topography and mechanical properties can also have a significant effect on the cellular processes.

Keywords: Biomaterials; Cardiac differentiation; Cardiac tissue engineering; Myocardial infarction; Stem cell fate.

PubMed Disclaimer

Figures

None
Graphical abstract
Fig. 1
Fig. 1
An overview of cell encapsulated scaffold-based cardiac tissue engineering process: Cells are seeded into scaffolds made of natural-derived or synthetic polymers, and the tissue constructs are then cultured in vitro under specific conditions to develop into mature tissues before implantation in vivo.
Fig. 2
Fig. 2
Biochemical and biophysical microenvironment properties that affect the fate of transplanted stem cells .
Fig. 3
Fig. 3
Matrix elasticity (A) and differentiation of seeded naive MSCs (B) .
Fig. 4
Fig. 4
Different cell cardiac differentiation extents, as indicated by protein expressions of CX43 (b,e) and CTnI (c,f) were observed in CDCs seeded in scaffolds with different fiber densities, fiber orientations and mechanical properties (a, d) .
Fig. 5
Fig. 5
Use of biodegradable (a) hydrogels based on NIPAAm, AAc and HEMAPTMC for the treatment of MI. (b) Increased LV wall thickness and capillary density were observed 8 weeks after gel injection; (c) H&E staining; (d) Immunohistochemical staining (blue: nuclear, green: α-SMA). Both of the images indicated the infiltration of cells into the hydrogels (black dots are the injected hydrogel area) .

References

    1. Rosamond W., Flegal K., Friday G., Furie K., Go A., Greenlund K. Heart disease and stroke statistics–2007 update: a report from the American heart association statistics committee and stroke statistics subcommittee. Circulation. 2007;115:e69–e171. - PubMed
    1. Taylor D.A. Cell-based myocardial repair: how should we proceed? International J. Cardiol. 2004;95(Suppl. 1):S8–S12. - PubMed
    1. Segers V.F., Lee R.T. Stem-cell therapy for cardiac disease. Nature. 2008;451:937–942. - PubMed
    1. Li S.C., Wang L., Jiang H., Acevedo J., Chang A.C., Loudon W.G. Stem cell engineering for treatment of heart diseases: potentials and challenges. Cell Biol. Int. 2009;33:255–267. - PubMed
    1. Nelson T.J., Martinez-Fernandez A., Yamada S., Perez-Terzic C., Ikeda Y., Terzic A. Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation. 2009;120:408–416. - PMC - PubMed